Klinikum St. Marien Amberg
About Klinikum St. Marien Amberg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
AIO-Studien-gGmbH
2
European Organisation for Research and Treatment of Cancer - EORTC
2
German CLL Study Group
2
AGO Research GmbH
1
Celgene
1
Dominik Paul Modest
1
Dr. Falk Pharma GmbH
1
Helsinn Healthcare SA
1
III. Medizinische Klinik Mannheim
1
Incyte Corporation
1
Clinical Trials at Klinikum St. Marien Amberg
During the past decade, Klinikum St. Marien Amberg conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on
average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
1999-07-01
Completed
96
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum St. Marien Amberg" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "AIO-Studien-gGmbH" with 2 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "German CLL Study Group" with 2 trials sponsored and "AGO Research GmbH"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum St. Marien Amberg"
#1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "AGO Breast Study Group e.V." with 1 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were
collaborators in the rest 21 trials.
Clinical Trials Conditions at Klinikum St. Marien Amberg
According to Clinical.Site data, the most researched conditions in "Klinikum St. Marien Amberg" are
"Lymphoma" (4 trials), "Breast Cancer" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Adenocarcinoma of the Stomach" (1 trials). Many other conditions were trialed in "Klinikum St. Marien Amberg" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum St. Marien Amberg
Most popular intervention types in "Klinikum St. Marien Amberg" are "Drug" (22 trials), "Biological" (6 trials), "Radiation" (5 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (5 trials), "radiation therapy" (5 trials), "doxorubicin hydrochloride" (4 trials), "filgrastim" (4 trials) and "prednisone" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum St. Marien Amberg
The vast majority of trials in "Klinikum St. Marien Amberg" are
17 trials for "All" genders and 7 trials for "Female" genders.
Clinical Trials Status at Klinikum St. Marien Amberg
Currently, there are NaN active trials in "Klinikum St. Marien Amberg".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Klinikum St. Marien Amberg,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum St. Marien Amberg, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Klinikum St. Marien Amberg
Klinikum St. Marien Amberg has several departments that took part in Clinical trials: "Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie" - 3 trials
Departments List
Name
City
Trials